Bioreactor options for continuous cell culture-derived viral vaccine 
production: less defective interfering particles through process intensification

Genzel, Yvonne; Tapia, Felipe; Vazquez-Ramirez, Daniel; Jordan, Ingo; Bürgin, Tim; Gangemi, David J.; Reichl, Udo

Lokale TagsFreigabegeschichteDetailsÜbersicht

Bioreactor options for continuous cell culture-derived viral vaccine production: less defective interfering particles through process intensification

Genzel, Y., Tapia, F., Vazquez-Ramirez, D., Jordan, I., Bürgin, T., Gangemi, D. J., et al. (2016). Bioreactor options for continuous cell culture-derived viral vaccine production: less defective interfering particles through process intensification. Talk presented at BioTech 2016: Biopharmaceutical Manufacturing and Single-Use Technologies. Waedenswil, Switzerland. 2016-09-05 - 2016-09-06.

Item is Freigegeben

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:

Datensatz-Permalink: https://hdl.handle.net/11858/00-001M-0000-002C-3214-5 Versions-Permalink: https://hdl.handle.net/11858/00-001M-0000-002C-4381-E

Genre: Vortrag

ausblenden:

Urheber:
Genzel, Yvonne¹, Autor
Tapia, Felipe^{1, 2}, Autor
Vazquez-Ramirez, Daniel¹, Autor
Jordan, Ingo³, Autor
Bürgin, Tim⁴, Autor
Gangemi, David J.⁵, Autor
Reichl, Udo^{1, 6}, Autor

Affiliations:
1Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society, ou_1738140
2International Max Planck Research School (IMPRS), Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society, ou_1738143
3ProBioGen AG, Berlin, Germany, ou_persistent22
4Adolf Kühner AG, Switzerland, ou_persistent22
5Viracell Advanced Products LLC, USA, ou_persistent22
6Otto-von-Guericke-Universität Magdeburg, External Organizations, ou_1738156